Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €8.94 EUR
Change Today +0.29 / 3.35%
Volume 501.0
ALMDT On Other Exchanges
EN Paris
As of 3:00 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

median technologies (ALMDT) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/22/15 - €8.94
52 Week Low
03/3/15 - €7.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

median technologies (ALMDT) Related Businessweek News

No Related Businessweek News Found

median technologies (ALMDT) Details

MEDIAN Technologies S.A. provides medical imaging products and integrated services for diagnosing and monitoring cancer patients in routine clinical practice and clinical drug development. The company’s products include MEDIAN CTIS, a change paradigm for image interpretation and management; and lesion management solutions for diagnosing and treating cancer patients. It also offers lung cancer screening imaging, clinical trial imaging, and managed services, as well as companion and monitoring tests. MEDIAN Technologies S.A. has strategic partnership with Canon, Inc.; Kuwait Life Science Company; and Quintiles. The company was founded in 2002 and is based in Valbonne, France.

Founded in 2002

median technologies (ALMDT) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: €233.0K
Co-Founder, Executive Vice President and Dire...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

median technologies (ALMDT) Key Developments

MEDIAN Technologies S.A. Reports Audited Earnings Results for the Full Year of 2014

MEDIAN Technologies S.A. reported audited earnings results for the full year of 2014. For the period, the company reported total turnover of EUR 1,518,000 compared to EUR 1,203,000 a year ago. Total operating income was EUR 3,282,000 compared to EUR 1,450,000 a year ago. Operating loss was EUR 5,725,000 compared to EUR 4,589,000 a year ago. Net loss was EUR 4,844,000 compared to EUR 4,348,000 a year ago.

MEDIAN Technologies S.A., Board Meeting, Apr 09, 2015

MEDIAN Technologies S.A., Board Meeting, Apr 09, 2015. Agenda: To consider and approve the annual statements for 2014.

MEDIAN Technologies Wins New Medical Image Interpretation and Management Projects for Clinical Trials

MEDIAN Technologies announced that it has been selected to provide imaging solutions and services for three new clinical studies in oncology. Taken together, these three new projects total approximately €2.76 million. A phase II study (non-small cell lung cancer - NSCLC) for a total of €1.08 million, A phase II study (colorectal cancer) for a total of €1.44 million and A phase II study (pancreatic adenocarcinoma) for a total of €248,000.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMDT:FP €8.94 EUR +0.29

ALMDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
MGT Capital Investments Inc $0.50 USD +0.0023
View Industry Companies

Industry Analysis


Industry Average

Valuation ALMDT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIAN TECHNOLOGIES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at